Biocon Ltd (BIOCON) - Financial and Strategic SWOT Analysis Review
August 2018
62
About the Report
About the Report
Biocon Ltd (BIOCON)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Biocon Ltd (Biocon) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions like cancer, diabetes and autoimmune. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and complex biologics both novels and biosimilars including monoclonal antibodies (MAbs), rh-Insulin and insulin analogs. It also provides research services including discovery, development and manufacturing services for both small and large molecules. Biocon provides research solutions to the biotechnology and pharmaceutical companies worldwide. It has an overseas manufacturing facility at BioXcell, a biotechnology park in Johor, Malaysia. Biocon is headquartered in Bangalore, Karnataka, India.
Biocon Ltd Key Recent Developments
Jul 26,2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr
Jul 04,2018: Biocon's Sterile Drug Product facility Receives EU GMP Certification
Jun 23,2018: Biocon's Sterile Drug Product facility Receives EIR from U.S. FDA
May 02,2018: Biocon Regulatory Audit Update
Apr 26,2018: Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma-Biocon Ltd]
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Biocon Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Sun Pharmaceutical Industries Ltd
Serum Institute of India Ltd
Piramal Enterprises Ltd
Panacea Biotec Ltd
Morepen Laboratories Ltd
Dr. Reddy's Laboratories Ltd
Bharat Immunologicals and Biologicals Corp Ltd
Abeona Therapeutics Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Biocon Ltd-Key Facts 6
Biocon Ltd-Key Employees 7
Biocon Ltd-Key Employee Biographies 8
Biocon Ltd-Major Products and Services 9
Biocon Ltd-History 12
Biocon Ltd-Company Statement 17
Biocon Ltd-Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 20
Section 2-Company Analysis 22
Company Overview 22
Biocon Ltd-Business Description 23
Business Segment: Biologics 23
Overview 23
Performance 23
Business Segment: Branded Formulations 23
Overview 23
Performance 23
Business Segment: Research Services 24
Overview 24
Performance 24
Business Segment: Small Molecules 24
Overview 24
Performance 24
Geographical Segment: India 24
Performance 24
Geographical Segment: Rest of the World 24
Performance 24
Geographical Segment: United States of America 24
Performance 24
R&D Overview 25
Biocon Ltd-Corporate Strategy 26
Biocon Ltd-SWOT Analysis 27
SWOT Analysis-Overview 27
Biocon Ltd-Strengths 27
Biocon Ltd-Weaknesses 28
Biocon Ltd-Opportunities 29
Biocon Ltd-Threats 30
Biocon Ltd-Key Competitors 31
Section 3-Company Financial Ratios 32
Financial Ratios-Capital Market Ratios 32
Financial Ratios-Annual Ratios 33
Performance Chart 36
Financial Performance 36
Financial Ratios-Interim Ratios 37
Financial Ratios-Ratio Charts 38
Section 4-Company's Lifesciences Financial Deals and Alliances 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40
Biocon Ltd, Recent Deals Summary 41
Section 5-Company's Recent Developments 42
Jul 26, 2018: Biocon Q1FY19 revenue Rs 1,193 Cr, Up 21%; EBITDA up 25% at Rs 307 Cr; net profit up 47% at Rs 120 Cr 42
Jul 04, 2018: Biocon's Sterile Drug Product facility Receives EU GMP Certification 45
Jun 23, 2018: Biocon's Sterile Drug Product facility Receives EIR from U.S. FDA 46
May 02, 2018: Biocon Regulatory Audit Update 47
Apr 26, 2018: Biocon Q4FY18 Revenue Rs 1,237 Cr, Up 27%; EBITDA Up 30% at Rs 300 Cr; Net Profit Up 2% at Rs 130 Cr[TOPC : Pharma-Biocon Ltd] 48
Mar 13, 2018: Update On Company Statement On US-FDA Inspection At Biocon Malaysia 51
Dec 13, 2017: Biocon's Clarification post media reports on Biocon on the FDA list for not paying facility fee 52
Nov 20, 2017: Biocon's Drug product Facility Receives EIR with VAI status, Inspection Closed 53
Oct 26, 2017: Biocon Q2FY18 Revenues at Rs 1019 Crore; EBITDA at Rs 233 Crore; Net Profit at Rs 69 Crore 54
Oct 25, 2017: Biocon Ranked Among Top 10 Global Pharma & Biotech Employers 57
Section 6-Appendix 58
Methodology 58
Ratio Definitions 58
About GlobalData 62
Contact Us 62
Disclaimer 62
List of Figure
List of Figures
Biocon Ltd, Performance Chart (2014-2018) 36
Biocon Ltd, Ratio Charts 38
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 40
List of Table
List of Tables
Biocon Ltd, Key Facts 6
Biocon Ltd, Key Employees 7
Biocon Ltd, Key Employee Biographies 8
Biocon Ltd, Major Products and Services 9
Biocon Ltd, History 12
Biocon Ltd, Subsidiaries 20
Biocon Ltd, Joint Venture 20
Biocon Ltd, Key Competitors 31
Biocon Ltd, Ratios based on current share price 32
Biocon Ltd, Annual Ratios 33
Biocon Ltd, Annual Ratios (Cont...1) 34
Biocon Ltd, Annual Ratios (Cont...2) 35
Biocon Ltd, Interim Ratios 37
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39
Biocon Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40
Biocon Ltd, Recent Deals Summary 41
Currency Codes 58
Capital Market Ratios 58
Equity Ratios 59
Profitability Ratios 59
Cost Ratios 60
Liquidity Ratios 60
Leverage Ratios 61
Efficiency Ratios 61
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.